Adaptive Biotechnologies
ADPT
ADPT
218 hedge funds and large institutions have $4B invested in Adaptive Biotechnologies in 2021 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 84 increasing their positions, 62 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
16% less capital invested
Capital invested by funds: $4.79B → $4B (-$791M)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
24% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 29
Holders
218
Holding in Top 10
4
Calls
$6.5M
Puts
$4.11M
Top Buyers
| 1 | +$27.6M | |
| 2 | +$16.6M | |
| 3 | +$16.3M | |
| 4 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$12.7M |
| 5 |
BlackRock
New York
|
+$9.19M |
Top Sellers
| 1 | -$50.7M | |
| 2 | -$26.6M | |
| 3 | -$14.8M | |
| 4 |
MCMC
Matrix Capital Management Company
Portsmouth,
New Hampshire
|
-$7.73M |
| 5 |
ZCI
Zevenbergen Capital Investments
Edmonds,
Washington
|
-$7.56M |